In a groundbreaking collaboration, the All India Institute of Medical Sciences (AIIMS), Delhi, and the Centre for Development of Advanced Computing (CDAC) have jointly introduced iOncology.ai, an Artificial Intelligence (AI) platform specifically crafted for the early detection of breast and ovarian cancer. 

This recent launch by AIIMS signifies a notable leap forward, harnessing state-of-the-art technology to enhance medical diagnostics.

CDAC, renowned for developing the world's fastest computer, brings an additional layer of technological expertise to this pioneering initiative. Dr. Ashok Sharma, Additional Professor in the Department of Biochemistry at Delhi-AIIMS, sheds light on the software, underscoring its pivotal role in efficiently diagnosing breast and ovarian cancers at an early stage while minimizing the risk of false negatives.

Addressing the significance of combating breast and ovarian cancers, major contributors to mortality rates, Dr. Sharma emphasizes the instrumental role of iOncology.ai. This software aids radiologists in tumor diagnosis, grading, and staging, serving as a valuable tool for early cancer detection. Future plans include expanding the software's capabilities to encompass oral cancer.

At the heart of the iOncology.ai platform lies a sophisticated AI system proficient in analyzing intricate medical data with unparalleled accuracy and efficiency. Leveraging deep learning models, the platform adapts and evolves, demonstrating self-learning capabilities as the volume of clinical and radiological/histopathological images increases.

Accumulating a vast dataset of approximately half a million radiological and histopathological images from around 1500 patient cases of breast and ovarian cancer at AIIMS, iOncology.ai's success was demonstrated when employed by the Department of Gynaecology and Dr. BRAIRCH/NCI of AIIMS on real patients to validate clinical examinations and diagnoses.

Buoyed by its success, the AI platform has been successfully implemented at five district hospitals across the country, marking a pivotal step in democratizing access to advanced cancer detection technologies. Dr. Sharma affirms that the platform holds significant potential to contribute to cancer diagnostics and treatment outcomes.

This pioneering collaboration exemplifies the synergy between AIIMS and CDAC, utilizing indigenous technology to address the pressing challenges posed by cancer. As iOncology.ai continues to evolve, it stands poised to become a transformative force in early cancer detection, potentially saving lives and reshaping the landscape of medical diagnostics in India.